| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Phobia (Neurophysiology)Learning and memory (Neurophysiology)DuloxetineQuetiapineEscitalopramPregabalinDepressionD CycloserineEndocannabinoidPeriaquaeductal grayAmygdalaCognitive behavior therapyNeuropeptide SPrefrontal cortex| 1 | 2003 | Generalized anxiety disorder. | 
| + | - | nl | South Med J 96(6):581-6 (2003) |
| 2 | 1999 | Anxiety disorders in children and adolescents. |
| + | - | nl | South Med J 92(10):946-54 (1999) |
| 3 | 2001 | Rages and refusals. Managing the many faces of adolescent anxiety. | 
| + | - | nl | Can Fam Physician 47(-):1023-30 (2001) |
| 4 | 1994 | Anxiety disorders in family practice. Diagnosis and management. |
| + | - | nl | Can Fam Physician 40(-):81-8 (1994) |
| 5 | 1993 | Anxiety disorders. Part 1: Diagnosis and treatment. |
| + | - | nl | Can Fam Physician 39(-):2194-8; 2201 (1993) |
| 6 | 1993 | Anxiety disorders. Part 2: Pharmacotherapy with benzodiazepines. |
| + | - | nl | Can Fam Physician 39(-):2205-8; 2211-3 (1993) |
| 7 | 1993 | Anxiety disorders. Focus on obsessive-compulsive disorder. |
| + | - | nl | Can Fam Physician 39(-):1612-21 (1993) |
| 8 | 2002 | Fear knot. Neurobiological disruption of long-term fear memory. |
| + | - | nl | Br J Psychiatry 180(-):195-7 (2002) |
| 9 | 2009 | The functional neuroanatomy of dread: Functional magnetic resonance imaging insights into generalized anxiety disorder and its treatment. |
| + | - | nl | Am J Psychiatry 166(3):263-5 (2009) Carter CS |
| 10 | 2007 | Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. |
| + | - | nl | Am J Psychiatry 164(10):1476-88 (2007) |
| 11 | 2007 | Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials. |
| + | - | nl | Am J Psychiatry 164(2):290-300 (2007) |
| 12 | 2003 | Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? |
| + | - | nl | Am J Psychiatry 160(8):1432-8 (2003) |
| 13 | 2000 | Neuroanatomical hypothesis of panic disorder, revised. |
| + | - | nl | Am J Psychiatry 157(4):493-505 (2000) |
| 14 | 1998 | Panic and phobic anxiety: defining phenotypes for genetic studies. |
| + | - | nl | Am J Psychiatry 155(9):1152-62 (1998) Smoller JW |
| 15 | 1998 | Panic and phobic anxiety: phenotypes, endophenotypes, and genotypes. |
| + | - | nl | Am J Psychiatry 155(9):1147-9 (1998) |
| 16 | 2009 | High anxieties: the social construction of anxiety disorders. |
| + | - | nl | Can J Psychiatry 54(7):429-36 (2009) |
| 17 | 2006 | Clinical practice guidelines. Management of anxiety disorders. |
| + | - | nl | Can J Psychiatry 51(8 Suppl 2):9S-91S (2006) |
| 18 | 2000 | Childhood anxiety disorders: lessons from the literature. |
| + | - | nl | Can J Psychiatry 45(8):724-30 (2000) |
| 19 | 1997 | Developments in anxiety disorders. |
| + | - | nl | Can J Psychiatry 42(10):1015-6 (1997) |
| 20 | 2008 | Relaxation training for anxiety: a ten-years systematic review with meta-analysis. |
| + | - | nl | BMC Psychiatry 8(-):41 (2008) |
| 21 | 2006 | Predicting danger: the nature, consequences, and neural mechanisms of predictive fear learning. |
| + | - | nl | Learn Mem 13(3):245-53 (2006) |
| 22 | 2004 | Emotional perseveration: an update on prefrontal-amygdala interactions in fear extinction. |
| + | - | nl | Learn Mem 11(5):525-35 (2004) |
| 23 | 2009 | Duloxetine for the treatment of generalized anxiety disorder: a review. |
| + | - | nl | Neuropsychiatr Dis Treat 5(-):23-31 (2009) |
| 24 | 2008 | New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine. |
| + | - | nl | Neuropsychiatr Dis Treat 4(6):1181-91 (2008) |
| 25 | 2008 | The role of duloxetine in the treatment of anxiety disorders. |
| + | - | nl | Neuropsychiatr Dis Treat 4(5):929-35 (2008) |
| 26 | 2008 | Pharmacotherapy of panic disorder. |
| + | - | nl | Neuropsychiatr Dis Treat 4(4):779-95 (2008) |
| 27 | 2007 | The therapeutic potential of escitalopram in the treatment of panic disorder. |
| + | - | nl | Neuropsychiatr Dis Treat 3(6):835-8 (2007) |
| 28 | 2007 | The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic. |
| + | - | nl | Neuropsychiatr Dis Treat 3(2):237-43 (2007) |
| 29 | 2006 | Experimental animal models for the simulation of depression and anxiety. |
| + | - | nl | Dialogues Clin Neurosci 8(3):323-33 (2006) |
| 30 | 2006 | Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. |
| + | - | nl | CNS Drug Rev 12(3-4):208-17 (2006) |
| 31 | 2007 | Modulation of fear and anxiety by the endogenous cannabinoid system. |
| + | - | nl | CNS Spectr 12(3):211-20 (2007) |
| 32 | 2007 | Clinical perspectives on the combination of D-cycloserine and cognitive-behavioral therapy for the treatment of anxiety disorders. |
| + | - | nl | CNS Spectr 12(1):51-6, 59-61 (2007) |
| 33 | 2006 | Efficacy of combined pharmacotherapy and psychotherapy versus monotherapy in the treatment of anxiety disorders. |
| + | - | nl | CNS Spectr 11(10 Suppl 12):29-33 (2006) |
| 34 | 2006 | Understanding the neurobiology of comorbidity in anxiety disorders. |
| + | - | nl | CNS Spectr 11(10 Suppl 12):13-20 (2006) |
| 35 | 2006 | Recent advances in the understanding and treatment of anxiety disorders. Resilience: determinants, measurement, and treatment responsiveness. |
| + | - | nl | CNS Spectr 11(10 Suppl 12):5-12 (2006) |
| 36 | 2004 | Generalized anxiety disorder: acute and chronic treatment. |
| + | - | nl | CNS Spectr 9(10):716-23 (2004) |
| 37 | 2009 | The pharmacologic treatment of patients with generalized anxiety disorder: where are we now and where are we going? |
| + | - | nl | CNS Spectr 14(2 Suppl 3):5-12 (2009) |
| 38 | 1997 | Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex. |
| + | - | nl | Philos Trans R Soc Lond B Biol Sci 352(1362):1675-87 (1997) |
| 39 | 2004 | Panic disorder: psychopathology, medical management and dental implications. |
| + | - | nl | J Am Dent Assoc 135(6):771-8; quiz 796-7 (2004) |
| 40 | 2003 | Anatomical connections of the periaqueductal gray: specific neural substrates for different kinds of fear. |
| + | - | nl | Braz J Med Biol Res 36(5):557-66 (2003) |
| 41 | 2003 | Pharmacology of human experimental anxiety. |
| + | - | nl | Braz J Med Biol Res 36(4):421-32 (2003) |
| 42 | 2001 | The brain decade in debate: II. Panic or anxiety? From animal models to a neurobiological basis. |
| + | - | nl | Braz J Med Biol Res 34(2):145-54 (2001) |
| 43 | 2009 | The anxiety disorder spectrum: fear imagery, physiological reactivity, and differential diagnosis. |
| + | - | nl | Anxiety Stress Coping 22(1):5-25 (2009) |
| 44 | 2010 | Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. |
| + | - | nl | Physiol Rev 90(2):419-63 (2010) |
| 45 | 2002 | A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety. |
| + | - | nl | Health Technol Assess 6(22):1-89 (2002) |
| 46 | 2011 | Anxiety disorders - assessment and management in general practice. |
| + | - | nl | Aust Fam Physician 40(6):370-4 (2011) |
| 47 | 2008 | Panic disorder. |
| + | - | nl | Clin Evid (Online) 2008(-):- (2008) |
| 48 | 2010 | Erasing fear memories with extinction training. |
| + | - | nl | J Neurosci 30(45):14993-7 (2010) |
| 49 | 2005 | Neuropeptide S: a new player in the modulation of arousal and anxiety. | 
| + | - | nl | Mol Interv 5(1):42-6 (2005) |
| 50 | 2010 | Prefrontal control of fear: more than just extinction. |
| + | - | nl | Curr Opin Neurobiol 20(2):231-5 (2010) |
